Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Brad Marder"'
Publikováno v:
Kidney360. 4:54-62
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e68e3d83c7595402c4230d7920270b5
https://doi.org/10.34067/kid.0005392022
https://doi.org/10.34067/kid.0005392022
Autor:
Kenneth Lieberman, Brad Marder, Abanti Chaudhuri, Kirk N. Campbell, Giovanni Gambaro, Peter T. Nelson, Esmat Mustafa, Kevin E.C. Meyers, Tarak Srivastava, Loreto Gesualdo, Sharon G. Adler, Radko Komers, Debbie S. Gipson, Howard Trachtman, Vladimir Tesar, Jai Radhakrishnan, Olga Zhdanova, Vimal K. Derebail, Miganush Stepanians, Jonathan J. Hogan
Publikováno v:
Journal of the American Society of Nephrology : JASN. 29(11)
Background We evaluated and compared the effects of sparsentan, a dual endothelin type A (ET A ) and angiotensin II type 1 receptor antagonist, with those of the angiotensin II type 1 receptor antagonist irbesartan in patients with primary FSGS. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2ad5013ec52230ce891e0144ab26db0
https://pubmed.ncbi.nlm.nih.gov/30361325
https://pubmed.ncbi.nlm.nih.gov/30361325
Autor:
Yaron Tomer, David A. Greenberg, Erlinda Concepcion, V. Ling, A. Kissin, Yoshiyuki Ban, Ronald Villanueva, Terry F. Davies, Brad Marder, Barbara Murphy, Giuseppe Barbesino
Publikováno v:
Genes & Immunity. 4:586-593
The cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) gene on 2q33 is associated with autoimmune thyroid diseases (AITDs). Our earlier study in 56 families showed linkage of 2q33 to the presence of thyroid antibodies (TAbs). The goals of this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6edd15e0d9f6c692b09f6b0f4b4fd802
https://doi.org/10.1038/sj.gene.6364018
https://doi.org/10.1038/sj.gene.6364018
Autor:
Rami Ashkan, Bernhard K. Krämer, Michael Fischereder, Bernd Schröppel, Bernd Krüger, Brad Marder, Carl Zülke, Barbara Murphy
Publikováno v:
Journal of the American Society of Nephrology. 13:2585-2589
Among the factors modulating transplant rejection and cardiovascular disease, chemokines and their respective receptors deserve special attention. In this respect, increased expression of MCP-1 and the corresponding receptor CCR2 have been demonstrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9d9c5ee21e85740f837a941c7ade2d5
https://doi.org/10.1097/01.asn.0000031701.53792.54
https://doi.org/10.1097/01.asn.0000031701.53792.54
Autor:
T. D. Schiano, Barbara Murphy, Bernd Schröppel, Marvin Lin, Michael Fischereder, Bernhard K. Krämer, Brad Marder
Publikováno v:
Journal of Clinical Immunology. 22:381-385
Chemokines and their receptors play a major role in the inflammatory and immune responses that mediate allograft outcome. The production of some chemokines varies among individuals and these variations may be determined by genetic polymorphisms, most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::173a8ad809335cfc0c51f4bdc099687d
https://doi.org/10.1023/a:1020612500935
https://doi.org/10.1023/a:1020612500935
Autor:
Bernd Schröppel, Yaron Tomer, Thomas D. Schiano, Rulan S. Parekh, Brad Marder, Barbara Murphy, Marvin Lin
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 3(4)
CTLA-4 and CD28 deliver opposing signals for T-cell proliferation. We examined single nucleotide polymorphisms (SNPs) CTLA-4 -318C/T and CD28 IVS3 +17T/C for associations with acute rejection in liver transplant recipients. These and two other polymo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b1fe85c9639591bab4736a86a78029c
https://pubmed.ncbi.nlm.nih.gov/12694064
https://pubmed.ncbi.nlm.nih.gov/12694064
Publikováno v:
Current opinion in urology. 13(2)
The purpose of this review is to summarize recent advances within the area of genetic polymorphisms with a specific emphasis on renal transplantation, and to discuss the potential clinical applications.Due to recent advances in molecular techniques,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb7e17f77c4ccd0dec8869080af1f7c0
https://pubmed.ncbi.nlm.nih.gov/12584466
https://pubmed.ncbi.nlm.nih.gov/12584466
Publikováno v:
Current Opinion in Urology; Mar2003, Vol. 13 Issue 2, p81-89, 9p